Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Sue Darcey
The industry trade group AdvaMed recently pointed to the 17 July US House passage of a bill to repeal the Affordable Care Act’s Cadillac tax as a pathway for repealing the device tax.
The US Medicare agency has decided that evidence is sufficient to cover ambulatory blood pressure monitoring to help diagnose hypertension in beneficiaries who suffer from white coat high blood pressure, and those with suspected masked hypertension.
A crop of new US consumer protection state laws and proposed federal legislation is aimed at stopping medical specialists from the practice of balance billing.
Prompted by a presidential executive order on advancing kidney health, the US Medicare agency has proposed five new end-stage renal disease (ESRD) payment models to encourage greater use of home dialysis and kidney transplants to Medicare and Medicaid beneficiaries.
The US Trade Representative’s Office has agreed to remove a group of medtech products and components from its list of those imported from China that initially would be tariffed at 25%, making its exclusion-from-tariffs decision retroactive one year, and extending the exclusion to 9 July 2020.
The Medical Device Manufacturers Association (MDMA) on 10 July praised US Senate reintroduction of the STRONGER Patents Act, designed to strengthen the US patents systems by making it easier and less costly for patent-holders to enforce their patents, including those which are the intellectual property of device-makers. Mirror legislation was simultaneously proposed in the US House.